Aimmune Therapeutics
-$0.10 (-0.29%) Today
$0.00 (0.00%) As of 11:11 PM UTC after-hours
Why Robinhood?
You can watch AIMT and buy or sell other stocks, options, and ETFs commission-free!
About AIMT
Aimmune Therapeutics is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies.
CEO
Andrew Oxtoby, MBA
Employees
—
Headquarters
Brisbane, California
Founded
2011
AIMT Key Statistics
Market cap
2.26B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.45M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$37.00
52 Week low
$10.09
AIMT Earnings
-$1.09
-$0.73
-$0.36
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours